meRfi®-GM
Immune Checkpoint Inhibitors (ICIs) Therapy
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
The response to Immune Checkpoint Inhibitors (ICIs) Therapy in cancer is currently predicted by different individual parameters – with varying degrees of accuracy: tumor mutation burden, tumor-infiltering T cell density, dendritic cell frequencies, and expression of checkpoint ligands.
see also:
Cancer Immunotherapy / Immuno-Oncology
…